Scar Treatment Global Market Report 2024

The scar treatment market has grown rapidly in recent years. It will grow from $21.88 billion in 2023 to $24.46 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The expansion observed during the historical period can be attributed to factors such as the integration of minimally invasive procedures, increased market accessibility, advancements in wound care, ongoing research and clinical trials, and the evolution of cosmetic surgery.

The scar treatment market is expected to see rapid growth in the next few years. It will grow to $36.97 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The anticipated growth in the forecast period can be ascribed to several factors, including innovative topical treatments, advancements in regenerative medicine, the evolution of cosmetic surgery techniques, the adoption of personalized treatment approaches, and the popularity of minimally invasive procedures. Noteworthy trends expected during the forecast period encompass an increased demand for aesthetic procedures, ongoing innovation in topical treatments, advancements in regenerative medicine, progress in cosmetic surgery techniques, and a growing emphasis on a patient-centric approach.

The anticipated rise in the number of road accidents is expected to drive the growth of the scar treatment market. Road accidents, defined as incidents involving at least one vehicle on a public road resulting in at least one person being injured or killed, often lead to accidental burns, abrasions, scrapes, or cuts that undergo a natural healing and tissue replacement process, leaving behind scars. The use of unique scar treatments can significantly reduce the appearance of these scars by addressing the damaged layers of skin and producing noticeable effects. For instance, in June 2022, a report from the RAC Foundation, a UK-based registered charity and transport policy organization, recorded a traffic collision resulting in an estimated 1,558 fatalities and 27,450 killed or seriously injured (KSI) casualties in 2021. Consequently, the escalating number of road accidents is a key driver for the growth of the scar treatment market.

The increasing number of surgical procedures is expected to contribute to the expansion of the scar treatment market. Surgical procedures, involving manual or instrumental techniques for diagnosing, treating, or curing medical conditions, injuries, or diseases through operative means, often result in scars. Scar treatment in surgical procedures aims to minimize the appearance of scars and offers benefits such as cosmetic improvement, enhanced healing, reduced discomfort, improved functionality, faster recovery, and overall improved patient outcomes. For example, according to the American Society for Metabolic and Bariatric Surgery (ASMBS) in June 2022, there was an increase in bariatric surgeries, reaching approximately 262,893 in 2021 compared to 198,651 in the previous period. Hence, the growing number of surgical procedures is a significant factor propelling the scar treatment market's growth.

Product innovation emerges as a prominent trend in the scar treatment market, with key players directing their efforts towards the development of inventive solutions to maintain their market standing. A notable example is SkinCeuticals Advanced Clinical Spa, a US-based cosmeceutical treatment company, which introduced "Advanced Scar Control" in September 2021. This silicone scar gel, with a high concentration, has been clinically proven to enhance the appearance of recent scars and prevent the development of new ones. The product boasts an undetectable, non-sticky, and non-greasy texture, offering long-lasting protection for optimal scar care. Its formulation not only minimizes scar appearance but also hydrates the skin and preserves its natural barrier function, inhibiting the formation of new scars.

Major companies in the scar treatment market are also directing their focus towards advanced solutions, such as diode laser systems, to drive revenue growth. Candela Corporation, a US-based medical aesthetics company, launched the Frax Pro System in March 2021. This cutting-edge diode laser system offers dual-depth skin resurfacing capabilities, providing non-ablative therapies and an enhanced option for skin resurfacing. The Frax Pro System represents Candela's commitment to introducing top-tier medical aesthetic energy-based devices to the market, building on a history of innovation in non-ablative treatments. Dermatologists and aesthetic professionals can now address a variety of skin conditions with this novel instrument.

In December 2021, Sanofi S.A., a France-based pharmaceutical and healthcare company, made an undisclosed acquisition of Origimm Biotechnology GmbH. This strategic move by Sanofi expands its vaccine R&D pipeline, knowledge in skin microbiome and immunology, and potential acne disease therapy options across Europe. Origimm Biotechnology GmbH, based in Austria, specializes in providing effective treatments for acne to prevent potential skin damage or scarring. This acquisition positions Sanofi to broaden its offerings in dermatological solutions and further strengthen its presence in the scar treatment market.

Major companies operating in the scar treatment market report are Smith & Nephew plc, Lumenis Ltd., Merz Pharmaceuticals GmbH, Sonoma Pharmaceuticals Inc., Cynosure LLC, CCA Industries Inc., Avita Medical Limited, Mölnlycke Health Care AB, Sientra Inc., Sisram Medical Ltd., Revitol Corporation, Scarguard Labs LLC, Scar Heal Inc., Enaltus LLC, Sumed International Ltd., Syneron Medical Ltd., Bausch Health Companies Inc., Hologic Inc., Beijing Toplaser Technology Co. Ltd., Pacific World Corporation, Suneva Medical Inc., Newmedical Technology Inc., Stratpharma AG, Perrigo Company plc, Alliance Pharma plc, Galderma Laboratories L.P., Acelity L.P. Inc., Advanced Medical Solutions Group plc, Aesthetic Factors LLC, Apyx Medical Corporation, Biofrontera AG, Cutera Inc., Derma Sciences Inc., Ellipse A/S, EndyMed Medical Ltd., Erchonia Corporation, Fotona d.o.o., InMode Ltd., Lutronic Corporation, Medtronic plc.

North America was the largest region in the scar treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global scar treatment market report during the forecast period. The regions covered in the scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the scar treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Various types of scars, including atrophic scars, hypertrophic and keloid scars, and contracture scars, require different treatments. Atrophic scars, characterized by depression and healing below the usual layer of skin tissue due to the skin's inability to repair itself, are a specific focus. Multiple treatment modalities, such as topical applications, laser therapy, surface treatments, surgical interventions, and injectable solutions, cater to the diverse needs of scar management. These treatments are utilized by a range of end-users, including hospitals, clinics, pharmacies, drug stores, and e-commerce platforms.

The scar treatment market research report provides scar treatment market statistics, including scar treatment industry global market size, regional shares, competitors with a scar treatment market share, detailed scar treatment market segments, market trends and opportunities, and any further data you may need to thrive in the scar treatment industry. This scar treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The scar treatment market includes revenues earned by entities by providing scar massage, early controlled exercise programs, and providing solution massage over the scars with various textures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.